These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20465104)

  • 21. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients.
    Gum PA; O'Keefe JH; Borkon AM; Spertus JA; Bateman TM; McGraw JP; Sherwani K; Vacek J; McCallister BD
    Circulation; 1997 Nov; 96(9 Suppl):II-7-10. PubMed ID: 9386067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
    Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
    J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
    Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA
    Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials).
    Lee TT; Feinberg L; Baim DS; Holmes DR; Aroesty JM; Carrozza JP; Cohen DJ; Ho KK; Cutlip DE
    Am J Cardiol; 2006 Sep; 98(6):718-21. PubMed ID: 16950169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.
    Ben-Gal Y; Moshkovitz Y; Nesher N; Uretzky G; Braunstein R; Hendler A; Zivi E; Herz I; Mohr R
    Ann Thorac Surg; 2006 Nov; 82(5):1692-7. PubMed ID: 17062230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: retrospective cohort study of 6320 procedures.
    Pell JP; Pell AC; Jeffrey RR; Jennings K; Oldroyd K; Eteiba H; Hogg KJ; Murday A; Faichney A; Colquhoun I; Berg G; Starkey IR; Flapan A; Mankad P
    Diabet Med; 2004 Jul; 21(7):790-2. PubMed ID: 15209776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coronary angioplasty in diabetic patients].
    Steffenino G; La Scala E; Riva L; Menardi E
    Ital Heart J Suppl; 2002 Jan; 3(1):9-15. PubMed ID: 11899579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?
    Klein LW
    J Am Coll Cardiol; 2006 Jan; 47(1):22-6. PubMed ID: 16386659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease.
    Buszman PP; Bochenek A; Konkolewska M; Trela B; Kiesz RS; Wilczyński M; Cisowski M; Krejca M; Banasiewicz-Szkróbka I; Krol M; Kondys M; Wiernek S; Orlik B; Martin JL; Tendera M; Buszman PE
    J Invasive Cardiol; 2009 Nov; 21(11):564-9. PubMed ID: 19901409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.
    Chocron S; Baillot R; Rouleau JL; Warnica WJ; Block P; Johnstone D; Myers MG; Calciu CD; Nozza A; Martineau P; van Gilst WH;
    Eur Heart J; 2008 Mar; 29(5):673-9. PubMed ID: 18285358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.
    Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Li JJ; Qin XW; Liu HB; Wu YJ; Chen J; Yao M; You SJ; Yuan JQ; Dai J; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):612-6. PubMed ID: 19323921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients.
    Chiu M; Ko DT; Austin PC; Cohen EA; Velianou JL; Goeree R; Blackhouse G; Tu JV
    Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):96-107. PubMed ID: 20031821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic options in patients with diabetes mellitus type 2 and coronary artery disease: intensified secondary prevention versus percutaneous or surgical revascularization].
    Sixt S; Schuler G; Niebauer J
    Dtsch Med Wochenschr; 2004 Jun; 129(24):1385-9. PubMed ID: 15188092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database.
    Kugelmass AD; Cohen DJ; Houser F; Mack M; Simon AW; Battaglia SL; Tarkington LG; Becker ER; Culler SD
    J Invasive Cardiol; 2003 Oct; 15(10):568-74. PubMed ID: 14519889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the risk of restenosis as a guide to triaging patients between surgical and percutaneous coronary revascularization.
    Kettelkamp R; House J; Garg M; Stuart RS; Grantham A; Spertus J
    Circulation; 2004 Sep; 110(11 Suppl 1):II50-4. PubMed ID: 15364838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.